M Kassem, M Kristiansen, BM Abdallah… - Basic & Clinical Pharmacology & Toxicology, 2004 - interscience.wiley.com Abstract: Mesenchymal stem cells are clonogenic, non-haematopoietic stem cells
present in the bone marrow and are able to differentiate into multiple
mesoderm-type cell lineages eg osteoblasts, chondrocytes, endothelial-cells ... Cited by 106 - Related articles - BL Direct - All 5 versions
- ►nih.gov KA Lapidos, YE Chen, JU Earley, A … - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Pluripotent bone marrow–derived side population (BM-SP) stem cells have been
shown to repopulate the hematopoietic system and to contribute to skeletal and
cardiac muscle regeneration after transplantation. We tested BM-SP cells ... Cited by 78 - Related articles - BL Direct - All 9 versions
- ►wisc.edu [PDF] DK Singla, TA Hacker, L Ma, PS Douglas, R … - Journal of molecular and cellular cardiology, 2006 - Elsevier Initial studies have suggested that transplantation of embryonic stem (ES) cells
following myocardial infarction (MI) in animal models is beneficial; however,
the mechanism of benefit is largely unknown. The present study investigated ... Cited by 69 - Related articles - All 14 versions
- ►ahajournals.org TJ O'Neill IV, BR Wamhoff, GK Owens, TC … - Circulation research, 2005 - Am Heart Assoc Bone marrow–derived cells (BMCs) have been implicated as a modifiers of
vascular growth either directly by transdifferentiation into endothelial cells
(ECs) or indirectly through growth factor release. To examine these ... Cited by 63 - Related articles - All 8 versions
- ►oxfordjournals.org S Fernandes, JC Amirault, G Lande, JM … - Cardiovascular research, 2006 - cardiovascres.oxfordjournals.org Methods and results: Seven days after coronary ligation, Wistar rats were
randomized into 3 groups: a control group receiving no further treatment, a
vehicle group injected with culture medium into the infarcted myocardium, ... Cited by 53 - Related articles - All 7 versions
- ►ersnet.org [PDF] P Aukrust, L Gullestad, T Ueland, JK Damås, … - Annals of Medicine, 2005 - informahealthcare.com Abstract Persistent inflammation, involving increased levels of inflammatory
cytokines, seems to play a pathogenic role in chronic heart failure (HF) by
influencing heart contractility, inducing hypertrophy and promoting ... Cited by 49 - Related articles - All 8 versions
J Jansen, S Hanks, JM Thompson, MJ Dugan, … - J Cell Mol Med, 2005 - interscience.wiley.com Hematopoietic stem cells can be collected from the peripheral blood. These
hematopoietic stem cells (HSC), or better progenitor cells, are mostly expressed
as the percentage of cells than react with CD34 antibodies or that form ... Cited by 45 - Related articles - All 2 versions
BM Abdallah, M Kassem - Gene Therapy, 2007 - nature.com Mesenchymal stem cells (MSC) are a group of clonogenic cells present among the
bone marrow stroma and capable of multilineage differentiation into
mesoderm-type cells such as osteoblasts, adipocytes and chondrocytes. Due ... Cited by 42 - Related articles - BL Direct - All 3 versions
- ►ahajournals.org D Mancini, D Burkhoff - Circulation, 2005 - Am Heart Assoc Despite advances in pharmacological treatments aimed at neurohormonal blockade
for heart failure in the setting of left ventricular pump dysfunction, there is
still a growing number of patients with advanced symptoms who suffer ... Cited by 38 - Related articles - All 7 versions
RD Nagy, BM Tsai, M Wang, TA Markel, JW … - Journal of Surgical Research, 2005 - Elsevier As a result, stem cells have the potential to undo irreversible cellular damage,
something traditional therapies could not cure. However, numerous issues must be
resolved to permit safe and effective clinical application of stem cell ... Cited by 35 - Related articles - All 12 versions
